141 related articles for article (PubMed ID: 38010402)
1. International medullary thyroid carcinoma grading system: an Indian tertiary care centre experience.
Rai V; Saha A; Mehta S; Shah RA; Trivedi P; Samanta ST; Rathod P; Manimaran P
Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1571-1579. PubMed ID: 38010402
[TBL] [Abstract][Full Text] [Related]
2. Independent Validation of the International Grading System for Medullary Thyroid Carcinoma: A Single Institution Experience.
Lubin DJ; Behrman DB; Goyal S; Magliocca K; Shi Q; Chen AY; Viswanathan K
Mod Pathol; 2023 Sep; 36(9):100235. PubMed ID: 37270155
[TBL] [Abstract][Full Text] [Related]
3. Grading medullary thyroid carcinoma on fine-needle aspiration cytology specimens with the International Medullary Thyroid Carcinoma Grading System: A cytologic-histologic correlation.
Viswanathan K; Behrman DB; Lubin DJ
Cancer Cytopathol; 2024 Apr; 132(4):224-232. PubMed ID: 38062948
[TBL] [Abstract][Full Text] [Related]
4. Tumor Grade Predicts for Calcitonin Doubling Times and Disease-Specific Outcomes After Resection of Medullary Thyroid Carcinoma.
Nigam A; Xu B; Spanheimer PM; Ganly I; Tuttle RM; Wong RJ; Shaha AR; Ghossein RA; Untch BR
Thyroid; 2022 Oct; 32(10):1193-1200. PubMed ID: 35950622
[No Abstract] [Full Text] [Related]
5. International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma.
Xu B; Fuchs TL; Ahmadi S; Alghamdi M; Alzumaili B; Bani MA; Baudin E; Chou A; De Leo A; Fagin JA; Ganly I; Glover A; Hartl D; Kanaan C; Khneisser P; Najdawi F; Nigam A; Papachristos A; Repaci A; Spanheimer PM; Solaroli E; Untch BR; Barletta JA; Tallini G; Al Ghuzlan A; Gill AJ; Ghossein RA
J Clin Oncol; 2022 Jan; 40(1):96-104. PubMed ID: 34731032
[TBL] [Abstract][Full Text] [Related]
6. Grading of Medullary Thyroid Carcinoma: an Interobserver Reproducibility Study.
Williams JF; Zhao M; Najdawi F; Ahmadi S; Hornick JL; Wong KS; Barletta JA
Endocr Pathol; 2022 Sep; 33(3):371-377. PubMed ID: 35553368
[TBL] [Abstract][Full Text] [Related]
7. External Validation of Three Available Grading Systems for Medullary Thyroid Carcinoma in a Single Institution Cohort.
Vissio E; Maletta F; Fissore J; Osella Abate S; Retta F; Brizzi MP; Piovesan A; Rossetto Giaccherino R; Volante M; Papotti M
Endocr Pathol; 2022 Sep; 33(3):359-370. PubMed ID: 35583706
[TBL] [Abstract][Full Text] [Related]
8. Exploration of Digital Image Analysis for Ki67 Quantification in the Grading of Medullary Thyroid Carcinoma: A Pilot Study with 85 Cases.
Behrman DB; Lubin DJ; Magliocca K; Shi Q; Viswanathan K
Head Neck Pathol; 2023 Sep; 17(3):638-646. PubMed ID: 37294412
[TBL] [Abstract][Full Text] [Related]
9. Grading system for medullary thyroid carcinoma; an institutional experience.
Podany P; Meiklejohn K; Garritano J; Holt EH; Barbieri A; Prasad M; Gilani SM
Ann Diagn Pathol; 2023 Jun; 64():152112. PubMed ID: 36736129
[TBL] [Abstract][Full Text] [Related]
10. A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis.
Fuchs TL; Nassour AJ; Glover A; Sywak MS; Sidhu SB; Delbridge LW; Clifton-Bligh RJ; Gild ML; Tsang V; Robinson BG; Clarkson A; Sheen A; Sioson L; Chou A; Gill AJ
Am J Surg Pathol; 2020 Oct; 44(10):1419-1428. PubMed ID: 32452872
[TBL] [Abstract][Full Text] [Related]
11. Medullary Thyroid Carcinomas Classified According to the International Medullary Carcinoma Grading System and a Surveillance, Epidemiology, and End Results-Based Metastatic Risk Score: A Correlation With Genetic Profile and Angioinvasion.
Torricelli F; Santandrea G; Botti C; Ragazzi M; Vezzani S; Frasoldati A; Ghidini A; Giordano D; Zanetti E; Rossi T; Nicoli D; Ciarrocchi A; Piana S
Mod Pathol; 2023 Sep; 36(9):100244. PubMed ID: 37307881
[TBL] [Abstract][Full Text] [Related]
12. Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome.
Alzumaili B; Xu B; Spanheimer PM; Tuttle RM; Sherman E; Katabi N; Dogan S; Ganly I; Untch BR; Ghossein RA
Mod Pathol; 2020 Sep; 33(9):1690-1701. PubMed ID: 32313184
[TBL] [Abstract][Full Text] [Related]
13. Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma.
Aksoy YA; Xu B; Viswanathan K; Ahadi MS; Al Ghuzlan A; Alzumaili B; Bani MA; Barletta JA; Chau N; Chou A; Clarkson A; Clifton-Bligh RJ; De Leo A; Dogan S; Ganly I; Ghossein R; Gild ML; Glover AR; Hadoux J; Lamartina L; Lubin DJ; Magliocca K; Najdawi F; Nigam A; Papachristos A; Repaci A; Robinson BG; Sheen A; Shi Q; Sidhu SB; Sioson L; Solaroli E; Sywak MS; Tallini G; Tsang V; Turchini J; Untch BR; Gill AJ; Fuchs TL
Histopathology; 2024 May; 84(6):947-959. PubMed ID: 38253940
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of grade in a genotyped cohort of sporadic medullary thyroid carcinomas.
Najdawi F; Ahmadi S; Capelletti M; Dong F; Chau NG; Barletta JA
Histopathology; 2021 Sep; 79(3):427-436. PubMed ID: 33763905
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
[TBL] [Abstract][Full Text] [Related]
16. High-grade medullary thyroid carcinoma with papillary-like nuclear features: A report of five cases.
Yamao N; Hirokawa M; Suzuki A; Higuchi M; Ishisaka T; Miyauchi A; Akamizu T
Diagn Cytopathol; 2024 Jan; 52(1):58-64. PubMed ID: 37846174
[TBL] [Abstract][Full Text] [Related]
17. An Undetectable Postoperative Calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study.
Duval MADS; Ferreira CV; Marmitt L; Dora JM; Espíndola M; Benini AF; Camelier MV; Bulzico D; Andrade FA; Alves Júnior PA; Corbo R; Vaisman F; Zanella AB; Scheffel RS; Maia AL
Thyroid; 2023 Jan; 33(1):82-90. PubMed ID: 36222615
[No Abstract] [Full Text] [Related]
18. Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma.
Jung CK; Agarwal S; Hang JF; Lim DJ; Bychkov A; Mete O
Endocr Pathol; 2023 Mar; 34(1):1-22. PubMed ID: 36890425
[TBL] [Abstract][Full Text] [Related]
19. Medullary Thyroid Carcinoma: Prognostic Variables And Tumour Markers Affecting Survival.
Hassan A; Siddique M; Riaz S; Khan AI; Nawaz MK; Bashir H
J Ayub Med Coll Abbottabad; 2018; 30(Suppl 1)(4):S627-S632. PubMed ID: 30838820
[TBL] [Abstract][Full Text] [Related]
20. Expression of Prox1 in Medullary Thyroid Carcinoma Is Associated with Chromogranin A and Calcitonin Expression and with Ki67 Proliferative Index, but Not with Prognosis.
Saglietti C; La Rosa S; Sykiotis GP; Letovanec I; Bulliard JL; Piana S; Mermod M; Petrova T; Uccella S; Sessa F; Bongiovanni M
Endocr Pathol; 2019 Jun; 30(2):138-145. PubMed ID: 31001799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
